Image of Dr. Nathanson's Lab

Nathanson Lab

The Nathanson Lab focuses on malignant brain tumors, in particular glioblastoma (GBM) – one of the most lethal of all cancers. We take an interdisciplinary approach to understand the biology of brain cancer and to develop innovative therapeutics to ultimately improve on patient outcomes.

Visit the Nathanson Lab
Ben and Catherine Ivy Foundation Logo

Ben & Catherine Ivy Foundation

The Ivy Brain Tumor Center is a non-profit translational research program that employs a bold, early-phase clinical trials strategy to identify new treatments for aggressive brain tumors, including glioblastoma.

Visit Ivy Foundation
COGNO Logo

COGNO

Cooperative Trials Group for Neuro-Oncology (COGNO) is a not-for-profit network of healthcare professionals, researchers and consumer representatives dedicated to improving survival and quality of life for people affected by brain and spinal tumors.

Visit COGNO
Sydney Clinical Trials Centre

NHMRC Clinical Trials Centre

The Sydney Clinical Trials Centre is a trusted leader in delivering high-quality clinical trials that improve health outcomes. Theyprovide end-to-end expertise across trial design, delivery, and advanced analysis, enabling partners to generate robust, decision-ready evidence.

Visit Sydney Clinical Trials Centre
Neosoma Inc. Logo

Neosoma

Neosoma maps, measures, tracks, and consolidates longitudinal lesion data through a powerful cloud software platform purpose-built for the multidisciplinary neuro-oncology team

Visit Neosoma
Female scientist

The Adult Brain Tumor Consortium (ABTC)

The Adult Brain Tumor Consortium (ABTC) is designed to develop more effective treatments for adults with brain cancers. It is comprised of a Central Operations Office, a Clinical Trials Research Program, and 11 brain tumor centers. It will introduce novel therapies using early phase clinical trials,

Learn about ABTC

Want to learn more or get involved?